BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17306669)

  • 1. First epidemiological data from the French Trophoblastic Disease Reference Center.
    Golfier F; Raudrant D; Frappart L; Mathian B; Guastalla JP; Trillet-Lenoir V; Vaudoyer F; Hajri T; Schott AM
    Am J Obstet Gynecol; 2007 Feb; 196(2):172.e1-5. PubMed ID: 17306669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of treatment relating to gestational trophoblastic tumor registered to the French Trophoblastic Disease Reference Center (TDRC) in Lyon from 1999 to 2005].
    Golfier F; Labrousse C; Frappart L; Mathian B; Guastalla JP; Trillet-Lenoir V; Hajri T; Schott AM; Raudrant D
    Gynecol Obstet Fertil; 2007 Mar; 35(3):205-15. PubMed ID: 17336125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twin pregnancy with complete hydatidiform mole and coexistent fetus: obstetrical and oncological outcomes in a series of 14 cases.
    Massardier J; Golfier F; Journet D; Frappart L; Zalaquett M; Schott AM; Lenoir VT; Dupuis O; Hajri T; Raudrant D
    Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):84-7. PubMed ID: 19193484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
    Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
    Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome.
    Hancock BW; Nazir K; Everard JE
    J Reprod Med; 2006 Oct; 51(10):764-6. PubMed ID: 17086803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subsequent pregnancy experience in patients with molar pregnancy and gestational trophoblastic tumor.
    Garner EI; Lipson E; Bernstein MR; Goldstein DP; Berkowitz RS
    J Reprod Med; 2002 May; 47(5):380-6. PubMed ID: 12063876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia.
    Garrett LA; Garner EI; Feltmate CM; Goldstein DP; Berkowitz RS
    J Reprod Med; 2008 Jul; 53(7):481-6. PubMed ID: 18720922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial sampling in patients with trophoblastic disease after suction curettage.
    Lertkhachonsuk R; Treratanachat S
    J Reprod Med; 2008 Aug; 53(8):634-8. PubMed ID: 18773630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gestational trophoblastic disease.
    Soper JT
    Obstet Gynecol; 2006 Jul; 108(1):176-87. PubMed ID: 16816073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity.
    Chalouhi GE; Golfier F; Soignon P; Massardier J; Guastalla JP; Trillet-Lenoir V; Schott AM; Raudrant D
    Am J Obstet Gynecol; 2009 Jun; 200(6):643.e1-6. PubMed ID: 19393597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal age-related rates of gestational trophoblastic disease.
    Altman AD; Bentley B; Murray S; Bentley JR
    Obstet Gynecol; 2008 Aug; 112(2 Pt 1):244-50. PubMed ID: 18669718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gestational trophoblastic disease in the Asian population of Northern England and North Wales.
    Tham BW; Everard JE; Tidy JA; Drew D; Hancock BW
    BJOG; 2003 Jun; 110(6):555-9. PubMed ID: 12798471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subsequent reproductive experience after treatment for gestational trophoblastic disease.
    Kim JH; Park DC; Bae SN; Namkoong SE; Kim SJ
    Gynecol Oncol; 1998 Oct; 71(1):108-12. PubMed ID: 9784329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gestational trophoblastic neoplasia: clinical trends in 8 years at Hospital Universitario de Caracas.
    Cortés-Charry R; Figueira LM; García-Barriola V; de Gómez M; Vivas Z; Salazar A
    J Reprod Med; 2006 Nov; 51(11):888-91. PubMed ID: 17165435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gestational trophoblastic disease: Regional perspective in Rio de Janeiro, Brazil.
    Belfort P; Baptista AM; Valle Filho OC
    J Reprod Med; 2010; 55(5-6):258-60. PubMed ID: 20626183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of women with recurrent molar pregnancies.
    Lorigan PC; Sharma S; Bright N; Coleman RE; Hancock BW
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):288-92. PubMed ID: 10985882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.